Skip to content

Impact of cardiopulmonary rehabilitation-embedded enhanced recovery after surgery program on post-operative prognosis of patients treated with CABG: rationale and design of a randomized controlled trial

Impact of cardiopulmonary rehabilitation-embedded enhanced recovery after surgery program on post-operative prognosis of patients treated with CABG: rationale and design of a randomized controlled trial

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300075125
Enrollment
Unknown
Registered
2023-08-25
Start date
2023-08-23
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease with coronary artery bypass grafting

Interventions

ERAS group:Usual care and ERAS.
pre CR-ERAS group:Usual care and pre CR-ERAS.
post CR-ERAS group:Usual care and post CR-ERAS.
peri CR-ERAS group:Usual care and peri CR-ERAS.

Sponsors

Department of Rehabilitation Medicine, the First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: (i) aged 18 years or older; (ii) diagnosed with coronary heart disease through coronary angiogram and laboratory examination based on symptoms and signs of the patient; (iii) met indications of CABG with or without valvular surgery defined as at least 2 vessel lesions or significant left major coronary arteries stenosis or SYNTAX score = 33; (iv) with normal cognition and being able to cooperate with the CR training; (v) agreed to participate in the trial and signed the consent form.

Exclusion criteria

Exclusion criteria: (i) pregnant; (ii) undergoing aortic surgery or equivalent surgery within 6 months; (iii) history of cardiogenic shock or sudden cardiac arrest and severe hypertension; (iv) having complications with persistent ischemia, hemodynamic impairment, or at risk of arterial occlusion with massive myocardial infarction; (v) having complications with severe cardiac insufficiency (NYHA of IV or LVEF<35%) and malignant arrhythmias; (vi) having acute myocardial infarction complicated with severe mechanical complications such as ventricular aneurysm formation, mitral regurgitation caused by papillary muscle rupture, or rupture of free wall; (vii) having peripheral neuropathy, peripheral artery disease, superficial thrombophlebitis, deep vein thrombosis, and thus unable to tolerate rehabilitation training; (viii) terminal disease like cancer, malignancies, liver failure, or other severe systemic diseasess, (ix) participated in other trials within 6 months.

Design outcomes

Primary

MeasureTime frame
Occurrence of post-operative cardiopulmonary complications occurring within the first 10 post-operative days;

Secondary

MeasureTime frame
Occurrence of post-operative pulmonary complications;Occurrence of post-operative cardiac complications;Occurrence of stroke;The occurrence of acute kidney injury;Delirium rate;Reintubation rate;The occurrence of revascularization;Early drainage tube removal rate;all-cause mortality;ICU readmission rate;Left ventricular ejection fraction (LVEF);metabolic equivalents (METs);the mechanical ventilation length;ICU Lenth of stay;Total lenth of stay;Total medical expenses;

Countries

CHINA

Contacts

Public ContactYu Zheng

the First Affiliated Hospital of Nanjing Medical University

zhengyu8710@163.com+86 173 2708 1766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 5, 2026